The global primary care POC diagnostics market size is expected to reach USD 8.6 billion by 2025, according to a new report by Grand View Research, Inc., registering a 3.5% CAGR during the forecast period. Flexible and forward-thinking core molecular labs have been embracing and supporting the use of POC tests to move screening of many common targets to hospital receiving rooms and physicians’ offices.
As
per a study conducted by the American Journal of Clinical Pathology in 2014, it
was found that POC testing improved clinical operations for manufacturers by
reducing follow-up calls and letters of patients by 85.0% and 89.0%,
respectively, and reducing their follow-up visits by 61.0%. It was also
observed that the number of tests ordered decreased by 21.0%.
Furthermore,
rise in the number of tests receiving a waived status under the Clinical
Laboratory Improvement Amendments of 1988 (CLIA) is anticipated to aid market
growth. Researchers and manufacturers are increasingly recommending these tests
owing to cost reduction of about USD 12-15 per patient and reduction in follow
up tests by about 50.0%. However, there is a massive overlap between different
methods and their areas of usage. For instance, panels to measure glucose and
quick international normalized ratio tests were originally meant for
self-testing but are now used in hospitals and primary settings instead.
For more info visit here: https://www.grandviewresearch.com/industry-analysis/primary-care-poc-diagnostics-market
Primary Care POC
Diagnostics Market Report Highlights
- By product,
the glucose testing segment accounted for the largest market share owing
to rising availability of a large number of products for glucose testing
that can be employed within primary care settings
- Increase in
out-patient practices for lipid testing as part of a routine checkup is
expected to positively enhance the adoption rate of lipid testing in the
market, giving it a prominent spot in the overall market by product
- In terms of
end use, while collaborative research for advanced and more accurate POC
testing kits by research institutes and biotech firms is likely to
facilitate the physicians’ office segment, government initiatives and
projects to extend primary care facilities will boost the non-practice
clinics segment
- The North
America primary care POC diagnostics market is more developed compared to the
rest of the world. The regional segment is fueled by availability of
several innovative and advanced POC diagnostic products and growing
awareness and demand for point-of-care diagnostics in primary home
healthcare and assisted healthcare
- The U.S. market
is witnessing a shift toward increasing patient involvement in home care,
home-based tests, and monitoring instruments. In addition, digitalization,
EHR, telemedicine, and web-enabled solutions of monitoring data are
gaining pace in U.S., thereby driving its growth
- Some of the
prominent players in the market are Quidel Corporation, Abbott
Laboratories, Instrumentation Laboratory, BD Biosciences, Roche
Diagnostics, Danaher Corporation, Siemens Healthcare, and bioMerieux.
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment